Results 141 to 150 of about 1,967,307 (350)

Trajectory of body shape in early and middle life and all cause and cause specific mortality: results from two prospective US cohort studies [PDF]

, 2016
Mingyang Song, Frank B. Hu, Kana Wu, Aviva Must, Andrew T. Chan, Walter C. Willett, Edward L. Giovannucci   +6 more
openalex   +1 more source

Aquaporin‐3 and aquaporin‐5 impact the development of pancreatic ductal adenocarcinoma spheroids

FEBS Open Bio, EarlyView.
Schematic representation of the role of aquaporin‐3 (AQP3) and aquaporin‐5 (AQP5) in pancreatic ductal adenocarcinoma (PDAC). Both proteins are upregulated in PDAC and are associated with tumor progression and metastatic potential. Silencing AQP3 or AQP5 in PDAC spheroids results in decreased diameter, area, and overall growth, underscoring their key ...
Catarina Pimpão, Diogo M. Engrácia, Graça Soveral, Filipa Mendes   +3 more
wiley   +1 more source

Impact of changes in specificity of data recording on cause-specific injury mortality in the United States, 1999–2010 [PDF]

, 2014
Guoqing Hu, Keita Mamady
openalex   +1 more source

Prognostic Impact of European LeukemiaNet Genetic Risk Stratification System in Adult Patients With Acute Myeloid Leukemia

Aging and Cancer, EarlyView.
This study aimed to evaluate the prognostic value of ELN2017 in predicting survival outcomes and to assess the impact of clinical and molecular factors such as age, FLT3 and NPM1 mutations, and allogeneic hematopoietic stem cell transplantation (allo‐HSCT).
Mobina Shrestha, Bishwas Mandal, Vishal Mandal, Asis Shrestha, Amir Babu Shrestha   +4 more
wiley   +1 more source

Trends in cause-specific mortality among people with type 2 and type 1 diabetes from 2002 to 2019: a Danish population-based studyResearch in context

The Lancet Regional Health. Europe
Summary: Background: Despite advances in primary and secondary prevention of cardiovascular disease, excess mortality persists within the diabetes population.
Tinne Laurberg, Susanne B. Graversen, Annelli Sandbæk, Sarah H. Wild, Rimke C. Vos, Henrik Støvring   +5 more
doaj   +1 more source

An Accounting of the Sources of Steller Sea Lion, Eumetopias jubatus, Mortality [PDF]

, 2000
During 1991–2000, the west-are additional mortalities that fueled the ern stock of Steller sea lions, Eumetopias decline. We tabulated the levels of reported jubatus, declined at 5.03% (SE = 0.25%) anthropogenic sources of mortality (sub- per year ...
Loughlin, Thomas R., York, Anne E.
core  

Using animations of risk functions to visualize trends in US all-cause and cause-specific mortality, 1968-2016

, 2020
S.R. Cole, D.B. Richardson, J.E. Rudolph, J.K. Edwards, M.L. Serre, E.A. Whitsel   +5 more
openalex   +1 more source

Re‐Awakening Public Attention to the Silent Pandemic of Cancer Among Older Adults in Low‐ and Middle‐Income Countries

Aging and Cancer, EarlyView.
ABSTRACT As global populations age, cancer is increasingly becoming a leading cause of morbidity and mortality among older adults, particularly in low‐ and middle‐income countries (LMICs). Despite accounting for the majority of new cancer cases and deaths, older individuals remain underrepresented in cancer research, clinical guidelines, and health ...
Ibrahim Bidemi Abdullateef, Sunkanmi Folorunsho, Abdulazeez Opeyemi Abdulganiyu   +2 more
wiley   +1 more source

Lifetime high occupational physical activity and total and cause-specific mortality among 320 000 adults in the NIH-AARP study: a cohort study.

, 2022
David Martinez Gomez, Pieter Coenen, Carlos Celis-Morales, Jorge Mota, Fernando Rodriguez-Artalejo, Charles Matthews, Pedro F Saint-Maurice   +6 more
openalex   +2 more sources

Risk Prediction Models for Recurrence After Curative Treatment of Early‐Stage or Locally Advanced Lung Cancer: A Systematic Review

Aging and Cancer, EarlyView.
This systematic review synthesizes prognostic models for survival and recurrence in resected non‐small cell lung cancer. While many models demonstrate moderate to good discrimination, few are externally validated and reporting quality is variable, limiting clinical applicability and highlighting the need for robust, transparent model development ...
Evangeline Samuel, S. Tissera, E. Paul, J. Zalcberg, R. G. Stirling   +4 more
wiley   +1 more source